Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
The breath biomarker panel is intended to support research to distinguish between chronic inflammatory airway diseases including asthma, COPD, and IPF.
Category: Respiratory Disease
Respiratory Disease
Latest
Respiratory Disease
Latest
Mologic Launches Clinical Trial to Identify Early Signs of COPD
The Headstart system is designed for home monitoring and integrates a simple, easy-to-use diagnostic with a reader and mobile phone app to capture patient-specific health data.
Respiratory Disease
Latest
Roche Expands Global Access Program to Include Diagnostics for Hepatitis, Human Papillomavirus, and Tuberculosis
Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals.
EliTechGroup Molecular Diagnostics Receives CE Mark for Respiratory Panel
liTechGroup Molecular Diagnostics has launched a multiplex assay, the respiratory bacterial Elite MGB panel, for the diagnosis of bacterial respiratory infections.
Read More
Third Hologic Respiratory Assay Obtains FDA Clearance
Running on the company’s Panther Fusion system, the new assay detects adenovirus, human metapneumovirus, and rhinovirus.
Read More
Respiratory Assay Cleared for Use on Panther Fusion System
Hologic has received premarket notification (510(k)) clearance from FDA for its Panther Fusion Flu A/B/RSV assay running on the company’s new Panther Fusion system.
Read More
IDbyDNA, ARUP Laboratories Introduce Technology to Diagnose Respiratory Infections
ARUP Laboratories and IDbyDNA have announced the launch of Explify Respiratory, a next-generation sequencing test for respiratory infections.
Read More
FDA Clears GenMark Instrument, Respiratory Pathogen Panel
The ePlex diagnostic platform integrates nucleic acid extraction, amplification, and detection into a fully automated, sample-to-answer system.
Read More
Advancing Tuberculosis Testing
Protecting sample stability ensures the utility of the latest generation of TB tests.
Read MoreProfessional Societies Issue Guidance on Molecular Diagnostics System for Respiratory Isolation Decisions
The US National Tuberculosis Controllers Association and the Association of Public Health Laboratories have recommended the use of the Xpert MTB/RIF test to support decisionmaking on using airborne infection isolation in healthcare settings.
Read More
Study Confirms Blood Test as Predictor of Tuberculosis Risk
The landmark NIH study represents a major advance in tuberculosis research.
Read MoreUSAID, Cepheid Join Forces to Battle Multidrug-Resistant Tuberculosis
Cepheid has signed a memorandum of understanding representing its intention to work with USAID to support the White House’s national action plan for combating MDR-TB.
Read More
FDA Clears Respiratory Pathogen Panel
The NxTag respiratory panel from Luminex enables laboratories to detect 20 respiratory pathogens simultaneously in a single closed-tube system.
Read MoreRespiratory Pathogen Panel Gets CE-IVD Mark
The closed-tube, scalable, 96-well based system from Luminex seeks to meet clinical demand for respiratory disease testing.
Read MoreReimbursement for Molecular Respiratory Pathogen Testing
Over time, the American Medical Association has established specific current procedural terminology codes to be used in reporting the results of testing by means of such multiplex molecular pathology panels.
Read MoreNonmolecular Methods for Respiratory Pathogen Testing
While viral culture is very sensitive, its long turnaround time, high cost, and requisite skill have made the method obsolete in most laboratories throughout the United States.
Read More
Respiratory Pathogen Testing
Flexible panel testing is the latest of many advances for the field.
Read More
Chinese Study Finds Tuberculin Skin Test Overestimates Latent TB Infection
In a head-to-head clinical study, Qiagen’s QFT test confirms lower prevalence of TB infection in China, and supports screening and preventive treatment for vulnerable populations.
Read More